Colorectal cancer and Blastocystis sp. infection

Blastocystis sp. is a common intestinal protozoan found worldwide. Based on gene analysis, 17 subtypes (STs, ST1-ST17) have been identified, 9 of which have been isolated from humans. Differences in clinical consequences may depend on differences among the STs. Here, we evaluated the prevalence of B...

Full description

Saved in:
Bibliographic Details
Published inParasites & vectors Vol. 14; no. 1; p. 200
Main Authors Sulżyc-Bielicka, Violetta, Kołodziejczyk, Lidia, Adamska, Małgorzata, Skotarczak, Bogumiła, Jaczewska, Sylwia, Safranow, Krzysztof, Bielicki, Paweł, Kładny, Józef, Bielicki, Dariusz
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 14.04.2021
BioMed Central
BMC
Subjects
Adult
Age
Age Factors
Aged
Aged, 80 and over
Asymptomatic
Bioethics
Blastocystis
Blastocystis - classification
Blastocystis - genetics
Blastocystis - isolation & purification
Blastocystis Infections - parasitology
Blastocystis Infections - pathology
Blastocystis sp
Cancer
Case-Control Studies
Chemotherapy
Colorectal cancer
Colorectal carcinoma
colorectal neoplasms
Colorectal Neoplasms - parasitology
Colorectal Neoplasms - pathology
Complications and side effects
Deoxyribonucleic acid
Disease control
DNA
DNA, Protozoan - genetics
Europe
Feces - parasitology
Female
genes
Health services
Humans
Infections
Intestine
intestines
Iodine
Irritable bowel syndrome
Light microscopy
Male
Men
Middle Aged
Multivariate analysis
Nucleotide sequence
Optical microscopy
Patients
PCR
Polymerase Chain Reaction
Protozoa
Protozoan diseases
risk
Risk factors
Sex
Sex Factors
ST subtypes
Statistical analysis
Statistics
Surgery
Tumors
Women
Poland
Iran
United States > US
Germany
Europe
Light microscopy
Blastocystis sp
ST subtypes
PCR
Colorectal cancer
Online AccessGet full text
ISSN1756-3305
1756-3305
DOI10.1186/s13071-021-04681-x

Cover

Abstract Blastocystis sp. is a common intestinal protozoan found worldwide. Based on gene analysis, 17 subtypes (STs, ST1-ST17) have been identified, 9 of which have been isolated from humans. Differences in clinical consequences may depend on differences among the STs. Here, we evaluated the prevalence of Blastocystis sp. in patients with colorectal cancer (CRC) compared to a control group and assessed the relationships between Blastocystis sp. infection and sex; age; and CRC grade, stage, and location. The study included 107 CRC patients (41 women and 66 men, median age 65 years); 124 subjects without colorectal cancer or a history of oncological disease comprised the control group (55 women and 69 men, median age 63). Stool samples were collected from patients before oncological treatment and examined using light microscopy (iodine-stained smear). Additionally, PCR-based identification of Blastocystis sp. was performed in 95 stool samples from CRC patients and 76 stool samples from the control group. Light microscopy showed that the prevalence of Blastocystis sp. was significantly higher in CRC patients than in the control group (12.15% and 2.42%, respectively; p = 0.0041). Multivariate analysis showed that the odds of Blastocystis sp. infection were fivefold higher in the CRC group than in the control group. PCR-based molecular examinations demonstrated that the proportion of patients infected with Blastocystis sp. was significantly higher in the CRC group than in the control group (12.63% and 2.63%, respectively; p = 0.023). The predominant ST in the CRC group was ST3, detected in nine patients (75%), followed by ST1 (2 patients, 16.7%) and ST2 (1 patient, 8.3%). No association was found between Blastocystis sp. infection and age, sex, or CRC stage, grade, or location. The results showed that CRC was associated with an increased risk of opportunistic Blastocystis sp. infection, even before oncological treatment. To the best of our knowledge, this is the first report estimating the prevalence of Blastocystis sp. infection in CRC patients before oncological treatment in Europe.
AbstractList Background Blastocystis sp. is a common intestinal protozoan found worldwide. Based on gene analysis, 17 subtypes (STs, ST1–ST17) have been identified, 9 of which have been isolated from humans. Differences in clinical consequences may depend on differences among the STs. Here, we evaluated the prevalence of Blastocystis sp. in patients with colorectal cancer (CRC) compared to a control group and assessed the relationships between Blastocystis sp. infection and sex; age; and CRC grade, stage, and location. Methods The study included 107 CRC patients (41 women and 66 men, median age 65 years); 124 subjects without colorectal cancer or a history of oncological disease comprised the control group (55 women and 69 men, median age 63). Stool samples were collected from patients before oncological treatment and examined using light microscopy (iodine-stained smear). Additionally, PCR-based identification of Blastocystis sp. was performed in 95 stool samples from CRC patients and 76 stool samples from the control group. Results Light microscopy showed that the prevalence of Blastocystis sp. was significantly higher in CRC patients than in the control group (12.15% and 2.42%, respectively; p = 0.0041). Multivariate analysis showed that the odds of Blastocystis sp. infection were fivefold higher in the CRC group than in the control group. PCR-based molecular examinations demonstrated that the proportion of patients infected with Blastocystis sp. was significantly higher in the CRC group than in the control group (12.63% and 2.63%, respectively; p = 0.023). The predominant ST in the CRC group was ST3, detected in nine patients (75%), followed by ST1 (2 patients, 16.7%) and ST2 (1 patient, 8.3%). No association was found between Blastocystis sp. infection and age, sex, or CRC stage, grade, or location. Conclusions The results showed that CRC was associated with an increased risk of opportunistic Blastocystis sp. infection, even before oncological treatment. To the best of our knowledge, this is the first report estimating the prevalence of Blastocystis sp. infection in CRC patients before oncological treatment in Europe.
Blastocystis sp. is a common intestinal protozoan found worldwide. Based on gene analysis, 17 subtypes (STs, ST1-ST17) have been identified, 9 of which have been isolated from humans. Differences in clinical consequences may depend on differences among the STs. Here, we evaluated the prevalence of Blastocystis sp. in patients with colorectal cancer (CRC) compared to a control group and assessed the relationships between Blastocystis sp. infection and sex; age; and CRC grade, stage, and location. The study included 107 CRC patients (41 women and 66 men, median age 65 years); 124 subjects without colorectal cancer or a history of oncological disease comprised the control group (55 women and 69 men, median age 63). Stool samples were collected from patients before oncological treatment and examined using light microscopy (iodine-stained smear). Additionally, PCR-based identification of Blastocystis sp. was performed in 95 stool samples from CRC patients and 76 stool samples from the control group. Light microscopy showed that the prevalence of Blastocystis sp. was significantly higher in CRC patients than in the control group (12.15% and 2.42%, respectively; p = 0.0041). Multivariate analysis showed that the odds of Blastocystis sp. infection were fivefold higher in the CRC group than in the control group. PCR-based molecular examinations demonstrated that the proportion of patients infected with Blastocystis sp. was significantly higher in the CRC group than in the control group (12.63% and 2.63%, respectively; p = 0.023). The predominant ST in the CRC group was ST3, detected in nine patients (75%), followed by ST1 (2 patients, 16.7%) and ST2 (1 patient, 8.3%). No association was found between Blastocystis sp. infection and age, sex, or CRC stage, grade, or location. The results showed that CRC was associated with an increased risk of opportunistic Blastocystis sp. infection, even before oncological treatment. To the best of our knowledge, this is the first report estimating the prevalence of Blastocystis sp. infection in CRC patients before oncological treatment in Europe.
Abstract Background Blastocystis sp. is a common intestinal protozoan found worldwide. Based on gene analysis, 17 subtypes (STs, ST1–ST17) have been identified, 9 of which have been isolated from humans. Differences in clinical consequences may depend on differences among the STs. Here, we evaluated the prevalence of Blastocystis sp. in patients with colorectal cancer (CRC) compared to a control group and assessed the relationships between Blastocystis sp. infection and sex; age; and CRC grade, stage, and location. Methods The study included 107 CRC patients (41 women and 66 men, median age 65 years); 124 subjects without colorectal cancer or a history of oncological disease comprised the control group (55 women and 69 men, median age 63). Stool samples were collected from patients before oncological treatment and examined using light microscopy (iodine-stained smear). Additionally, PCR-based identification of Blastocystis sp. was performed in 95 stool samples from CRC patients and 76 stool samples from the control group. Results Light microscopy showed that the prevalence of Blastocystis sp. was significantly higher in CRC patients than in the control group (12.15% and 2.42%, respectively; p = 0.0041). Multivariate analysis showed that the odds of Blastocystis sp. infection were fivefold higher in the CRC group than in the control group. PCR-based molecular examinations demonstrated that the proportion of patients infected with Blastocystis sp. was significantly higher in the CRC group than in the control group (12.63% and 2.63%, respectively; p = 0.023). The predominant ST in the CRC group was ST3, detected in nine patients (75%), followed by ST1 (2 patients, 16.7%) and ST2 (1 patient, 8.3%). No association was found between Blastocystis sp. infection and age, sex, or CRC stage, grade, or location. Conclusions The results showed that CRC was associated with an increased risk of opportunistic Blastocystis sp. infection, even before oncological treatment. To the best of our knowledge, this is the first report estimating the prevalence of Blastocystis sp. infection in CRC patients before oncological treatment in Europe.
Background Blastocystis sp. is a common intestinal protozoan found worldwide. Based on gene analysis, 17 subtypes (STs, ST1-ST17) have been identified, 9 of which have been isolated from humans. Differences in clinical consequences may depend on differences among the STs. Here, we evaluated the prevalence of Blastocystis sp. in patients with colorectal cancer (CRC) compared to a control group and assessed the relationships between Blastocystis sp. infection and sex; age; and CRC grade, stage, and location. Methods The study included 107 CRC patients (41 women and 66 men, median age 65 years); 124 subjects without colorectal cancer or a history of oncological disease comprised the control group (55 women and 69 men, median age 63). Stool samples were collected from patients before oncological treatment and examined using light microscopy (iodine-stained smear). Additionally, PCR-based identification of Blastocystis sp. was performed in 95 stool samples from CRC patients and 76 stool samples from the control group. Results Light microscopy showed that the prevalence of Blastocystis sp. was significantly higher in CRC patients than in the control group (12.15% and 2.42%, respectively; p = 0.0041). Multivariate analysis showed that the odds of Blastocystis sp. infection were fivefold higher in the CRC group than in the control group. PCR-based molecular examinations demonstrated that the proportion of patients infected with Blastocystis sp. was significantly higher in the CRC group than in the control group (12.63% and 2.63%, respectively; p = 0.023). The predominant ST in the CRC group was ST3, detected in nine patients (75%), followed by ST1 (2 patients, 16.7%) and ST2 (1 patient, 8.3%). No association was found between Blastocystis sp. infection and age, sex, or CRC stage, grade, or location. Conclusions The results showed that CRC was associated with an increased risk of opportunistic Blastocystis sp. infection, even before oncological treatment. To the best of our knowledge, this is the first report estimating the prevalence of Blastocystis sp. infection in CRC patients before oncological treatment in Europe. Keywords: Colorectal cancer, Blastocystis sp., ST subtypes, PCR, Light microscopy
Blastocystis sp. is a common intestinal protozoan found worldwide. Based on gene analysis, 17 subtypes (STs, ST1-ST17) have been identified, 9 of which have been isolated from humans. Differences in clinical consequences may depend on differences among the STs. Here, we evaluated the prevalence of Blastocystis sp. in patients with colorectal cancer (CRC) compared to a control group and assessed the relationships between Blastocystis sp. infection and sex; age; and CRC grade, stage, and location.BACKGROUNDBlastocystis sp. is a common intestinal protozoan found worldwide. Based on gene analysis, 17 subtypes (STs, ST1-ST17) have been identified, 9 of which have been isolated from humans. Differences in clinical consequences may depend on differences among the STs. Here, we evaluated the prevalence of Blastocystis sp. in patients with colorectal cancer (CRC) compared to a control group and assessed the relationships between Blastocystis sp. infection and sex; age; and CRC grade, stage, and location.The study included 107 CRC patients (41 women and 66 men, median age 65 years); 124 subjects without colorectal cancer or a history of oncological disease comprised the control group (55 women and 69 men, median age 63). Stool samples were collected from patients before oncological treatment and examined using light microscopy (iodine-stained smear). Additionally, PCR-based identification of Blastocystis sp. was performed in 95 stool samples from CRC patients and 76 stool samples from the control group.METHODSThe study included 107 CRC patients (41 women and 66 men, median age 65 years); 124 subjects without colorectal cancer or a history of oncological disease comprised the control group (55 women and 69 men, median age 63). Stool samples were collected from patients before oncological treatment and examined using light microscopy (iodine-stained smear). Additionally, PCR-based identification of Blastocystis sp. was performed in 95 stool samples from CRC patients and 76 stool samples from the control group.Light microscopy showed that the prevalence of Blastocystis sp. was significantly higher in CRC patients than in the control group (12.15% and 2.42%, respectively; p = 0.0041). Multivariate analysis showed that the odds of Blastocystis sp. infection were fivefold higher in the CRC group than in the control group. PCR-based molecular examinations demonstrated that the proportion of patients infected with Blastocystis sp. was significantly higher in the CRC group than in the control group (12.63% and 2.63%, respectively; p = 0.023). The predominant ST in the CRC group was ST3, detected in nine patients (75%), followed by ST1 (2 patients, 16.7%) and ST2 (1 patient, 8.3%). No association was found between Blastocystis sp. infection and age, sex, or CRC stage, grade, or location.RESULTSLight microscopy showed that the prevalence of Blastocystis sp. was significantly higher in CRC patients than in the control group (12.15% and 2.42%, respectively; p = 0.0041). Multivariate analysis showed that the odds of Blastocystis sp. infection were fivefold higher in the CRC group than in the control group. PCR-based molecular examinations demonstrated that the proportion of patients infected with Blastocystis sp. was significantly higher in the CRC group than in the control group (12.63% and 2.63%, respectively; p = 0.023). The predominant ST in the CRC group was ST3, detected in nine patients (75%), followed by ST1 (2 patients, 16.7%) and ST2 (1 patient, 8.3%). No association was found between Blastocystis sp. infection and age, sex, or CRC stage, grade, or location.The results showed that CRC was associated with an increased risk of opportunistic Blastocystis sp. infection, even before oncological treatment. To the best of our knowledge, this is the first report estimating the prevalence of Blastocystis sp. infection in CRC patients before oncological treatment in Europe.CONCLUSIONSThe results showed that CRC was associated with an increased risk of opportunistic Blastocystis sp. infection, even before oncological treatment. To the best of our knowledge, this is the first report estimating the prevalence of Blastocystis sp. infection in CRC patients before oncological treatment in Europe.
Blastocystis sp. is a common intestinal protozoan found worldwide. Based on gene analysis, 17 subtypes (STs, ST1-ST17) have been identified, 9 of which have been isolated from humans. Differences in clinical consequences may depend on differences among the STs. Here, we evaluated the prevalence of Blastocystis sp. in patients with colorectal cancer (CRC) compared to a control group and assessed the relationships between Blastocystis sp. infection and sex; age; and CRC grade, stage, and location. The study included 107 CRC patients (41 women and 66 men, median age 65 years); 124 subjects without colorectal cancer or a history of oncological disease comprised the control group (55 women and 69 men, median age 63). Stool samples were collected from patients before oncological treatment and examined using light microscopy (iodine-stained smear). Additionally, PCR-based identification of Blastocystis sp. was performed in 95 stool samples from CRC patients and 76 stool samples from the control group. Light microscopy showed that the prevalence of Blastocystis sp. was significantly higher in CRC patients than in the control group (12.15% and 2.42%, respectively; p = 0.0041). Multivariate analysis showed that the odds of Blastocystis sp. infection were fivefold higher in the CRC group than in the control group. PCR-based molecular examinations demonstrated that the proportion of patients infected with Blastocystis sp. was significantly higher in the CRC group than in the control group (12.63% and 2.63%, respectively; p = 0.023). The predominant ST in the CRC group was ST3, detected in nine patients (75%), followed by ST1 (2 patients, 16.7%) and ST2 (1 patient, 8.3%). No association was found between Blastocystis sp. infection and age, sex, or CRC stage, grade, or location. The results showed that CRC was associated with an increased risk of opportunistic Blastocystis sp. infection, even before oncological treatment. To the best of our knowledge, this is the first report estimating the prevalence of Blastocystis sp. infection in CRC patients before oncological treatment in Europe.
ArticleNumber 200
Audience Academic
Author Sulżyc-Bielicka, Violetta
Jaczewska, Sylwia
Safranow, Krzysztof
Bielicki, Paweł
Adamska, Małgorzata
Bielicki, Dariusz
Kładny, Józef
Kołodziejczyk, Lidia
Skotarczak, Bogumiła
Author_xml – sequence: 1
  givenname: Violetta
  orcidid: 0000-0001-7542-1414
  surname: Sulżyc-Bielicka
  fullname: Sulżyc-Bielicka, Violetta
– sequence: 2
  givenname: Lidia
  surname: Kołodziejczyk
  fullname: Kołodziejczyk, Lidia
– sequence: 3
  givenname: Małgorzata
  surname: Adamska
  fullname: Adamska, Małgorzata
– sequence: 4
  givenname: Bogumiła
  surname: Skotarczak
  fullname: Skotarczak, Bogumiła
– sequence: 5
  givenname: Sylwia
  surname: Jaczewska
  fullname: Jaczewska, Sylwia
– sequence: 6
  givenname: Krzysztof
  surname: Safranow
  fullname: Safranow, Krzysztof
– sequence: 7
  givenname: Paweł
  surname: Bielicki
  fullname: Bielicki, Paweł
– sequence: 8
  givenname: Józef
  surname: Kładny
  fullname: Kładny, Józef
– sequence: 9
  givenname: Dariusz
  surname: Bielicki
  fullname: Bielicki, Dariusz
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33853659$$D View this record in MEDLINE/PubMed
BookMark eNqNkl2L1DAUhoOsuB_6B7yQgjfuRcd8N7kR1sHVgQXBj-uQpumYoZOMSbrM_nvTnXXdLiISSsLp8749OX1PwZEP3gLwEsEFQoK_TYjABtUQl4dyger9E3CCGsZrQiA7enA-BqcpbSDkUDL-DBwTIhjhTJ4AuAxDiNZkPVRGe2NjpX1XvR90ysHcpOxSlXaLyvm-QC745-Bpr4dkX9ztZ-D75Ydvy0_11eePq-XFVW04gbnWAmkBOSWyw7Lvm6Z8m2PJrdbWYkkg7hvJMbYtNsZAxnmLOtIy2gsmKcbkDKwOvl3QG7WLbqvjjQraqdtCiGulY3ZmsAqxThsoGBaYUtoIUW5msO6l5KSVsCte7w5eu7Hd2s5Yn6MeZqbzN979UOtwrQSkAsmpmTd3BjH8HG3KauuSscOgvQ1jUphhignH5H9QRDBljJGCvn6EbsIYfZnqRFFBRUPgH2qty13LfwilRTOZqgvORDGCBBVq8ReqrM5unSm56V2pzwTnM0Fhst3ntR5TUquvX-bsq4fzux_c7xgVAB8AE0NK0fb3CIJqyqo6ZFWVrKrbrKp9EYlHIuOynjJWWnfDv6S_AH8i6BA
CitedBy_id crossref_primary_10_1186_s13071_022_05418_0
crossref_primary_10_3390_biology11121742
crossref_primary_10_3390_microorganisms12091924
crossref_primary_10_1186_s13027_022_00447_x
crossref_primary_10_1186_s13099_024_00613_z
crossref_primary_10_61186_sjku_27_6_88
crossref_primary_10_1016_j_actatropica_2025_107537
crossref_primary_10_3389_fcimb_2022_961974
crossref_primary_10_3390_cancers14215342
crossref_primary_10_3390_cancers15030748
crossref_primary_10_3390_pathogens14040313
crossref_primary_10_1053_j_gastro_2024_11_019
crossref_primary_10_3390_jcm11102847
crossref_primary_10_1038_s41598_023_42456_9
crossref_primary_10_1007_s11686_022_00628_z
crossref_primary_10_1016_j_jinorgbio_2023_112307
crossref_primary_10_29089_paom_188591
crossref_primary_10_1016_j_actatropica_2022_106577
crossref_primary_10_3389_fonc_2023_1115835
crossref_primary_10_1186_s12879_024_10235_0
crossref_primary_10_2478_fco_2021_0009
crossref_primary_10_4274_tpd_galenos_2023_33042
crossref_primary_10_3389_fcimb_2022_1019789
crossref_primary_10_3390_ani12030291
crossref_primary_10_1007_s00436_022_07761_8
crossref_primary_10_1007_s00436_023_07972_7
crossref_primary_10_1111_jeu_12978
Cites_doi 10.1016/j.trstmh.2011.12.008
10.1038/nrmicro2819
10.1038/s41575-019-0209-8
10.1158/0008-5472.CAN-16-3472
10.1046/j.1365-3156.1997.d01-383.x
10.1007/s00436-010-1764-7
10.1038/ni.3384
10.1016/j.jiph.2017.03.009
10.4269/ajtmh.2009.80.588
10.1371/journal.pone.0111868
10.1136/gutjnl-2018-317200
10.1136/gutjnl-2016-313235
10.1016/j.parint.2016.05.007
10.1038/ismej.2017.139
10.3389/fmed.2020.606298
10.1016/j.parint.2016.05.015
10.1186/1756-3305-7-162
10.1007/s00436-013-3538-5
10.1371/journal.pone.0183097
10.1016/j.mcp.2007.06.007
10.1038/s41591-019-0406-6
10.1056/NEJM200007133430201
10.1016/j.ccell.2018.03.004
10.2174/1381612824666180807101536
10.1186/s13027-017-0131-z
10.1002/ijc.21731
10.1128/JCM.38.4.1324-1330.2000
10.1111/1574-6941.12396
10.1016/j.pt.2007.01.004
10.1007/s00436-008-1031-3
10.1038/s41591-019-0405-7
10.1016/j.pt.2018.02.004
10.1007/s00436-018-6070-9
10.1007/s00436-008-1198-7
10.1038/nature13828
10.1101/gr.126516.111
10.1136/gutjnl-2018-317178
10.3109/00365548.2013.861609
10.1080/00365521.2016.1216587
10.1007/s00436-008-1163-5
10.1136/gutjnl-2014-307241
10.4103/2229-5070.113896
10.1016/j.meegid.2013.07.020
10.1007/s00436-007-0808-0
10.1007/s00436-011-2788-3
10.1016/j.vetpar.2004.09.017
10.1371/journal.ppat.1002545
10.15403/jgld.2014.1121.254.yiz
10.1136/gutjnl-2013-304833
10.1128/JCM.43.1.348-355.2005
10.1016/j.parint.2008.01.004
10.3389/fcimb.2012.00141
10.3748/wjg.v20.i5.1192
10.1038/nrmicro3344
10.1016/j.arcmed.2017.11.015
10.1017/S0031182013000255
10.1007/s00436-007-0833-z
10.15252/msb.20145645
10.1136/gutjnl-2015-309800
10.3855/jidc.8179
10.1186/s12879-016-1776-8
10.4269/ajtmh.2008.79.401
10.1016/j.parint.2016.02.010
10.1128/JCM.02520-15
10.1007/s00436-012-3085-5
10.1038/ncomms7528
10.1053/j.gastro.2014.02.009
10.1093/molbev/msr121
10.1016/j.parint.2017.01.005
ContentType Journal Article
Copyright COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021
Copyright_xml – notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
3V.
7SN
7SS
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
F1W
FYUFA
GHDGH
H95
K9.
L.G
M0S
M1P
M7N
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
7S9
L.6
5PM
DOA
DOI 10.1186/s13071-021-04681-x
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Ecology Abstracts
Entomology Abstracts (Full archive)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central Korea
ASFA: Aquatic Sciences and Fisheries Abstracts
Health Research Premium Collection
Health Research Premium Collection (Alumni)
Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources
ProQuest Health & Medical Complete (Alumni)
Aquatic Science & Fisheries Abstracts (ASFA) Professional
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Aquatic Science & Fisheries Abstracts (ASFA) Professional
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ASFA: Aquatic Sciences and Fisheries Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList Publicly Available Content Database



MEDLINE - Academic

MEDLINE
AGRICOLA
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Zoology
Statistics
EISSN 1756-3305
EndPage 200
ExternalDocumentID oai_doaj_org_article_15dac085282444788659c2af9963b90d
PMC8048192
A658553031
33853659
10_1186_s13071_021_04681_x
Genre Journal Article
GeographicLocations Poland
Iran
United States--US
Germany
Europe
GeographicLocations_xml – name: Poland
– name: Iran
– name: Germany
– name: United States--US
– name: Europe
GrantInformation_xml – fundername: grant number WLBiML-418-02/S/12/2019, https://www.pum.edu.pl.
  grantid: WLBiML-418-02/S/12/2019
– fundername: ;
  grantid: WLBiML-418-02/S/12/2019
GroupedDBID ---
0R~
123
29O
2WC
2XV
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
ECGQY
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ISR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
UKHRP
~8M
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7SN
7SS
7XB
8FK
AZQEC
C1K
DWQXO
F1W
H95
K9.
L.G
M7N
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
7S9
L.6
5PM
PUEGO
ID FETCH-LOGICAL-c630t-a81a806439d29ff770606296eaaee29302f79622eb2ccc0566b1d3b54f8594223
IEDL.DBID M48
ISSN 1756-3305
IngestDate Wed Aug 27 01:26:49 EDT 2025
Thu Aug 21 18:21:53 EDT 2025
Fri Jul 11 06:18:02 EDT 2025
Mon Jul 21 11:21:14 EDT 2025
Sat Jul 26 02:23:31 EDT 2025
Tue Jun 17 21:48:40 EDT 2025
Tue Jun 10 20:25:16 EDT 2025
Fri Jun 27 03:46:16 EDT 2025
Thu Apr 03 07:05:19 EDT 2025
Thu Apr 24 23:00:13 EDT 2025
Tue Jul 01 00:54:07 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Light microscopy
Blastocystis sp
ST subtypes
PCR
Colorectal cancer
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c630t-a81a806439d29ff770606296eaaee29302f79622eb2ccc0566b1d3b54f8594223
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-7542-1414
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s13071-021-04681-x
PMID 33853659
PQID 2514848730
PQPubID 55241
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_15dac085282444788659c2af9963b90d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8048192
proquest_miscellaneous_2524236232
proquest_miscellaneous_2513245553
proquest_journals_2514848730
gale_infotracmisc_A658553031
gale_infotracacademiconefile_A658553031
gale_incontextgauss_ISR_A658553031
pubmed_primary_33853659
crossref_primary_10_1186_s13071_021_04681_x
crossref_citationtrail_10_1186_s13071_021_04681_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-04-14
PublicationDateYYYYMMDD 2021-04-14
PublicationDate_xml – month: 04
  year: 2021
  text: 2021-04-14
  day: 14
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Parasites & vectors
PublicationTitleAlternate Parasit Vectors
PublicationYear 2021
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References A Cougnoux (4681_CR46) 2016; 65
F Beghini (4681_CR14) 2017; 11
CR Stensvold (4681_CR18) 2013; 3
LO Andersen (4681_CR23) 2016; 54
P Poirier (4681_CR11) 2012; 8
PG Menounos (4681_CR6) 2008; 22
A Moosavi (4681_CR30) 2012; 111
EM Hussein (4681_CR27) 2008; 102
D ElSafadi (4681_CR31) 2016; 16
H Yoshikawa (4681_CR32) 2000; 38
KS Tan (4681_CR7) 2004; 126
PD Scanlan (4681_CR13) 2014; 90
AM Thomas (4681_CR38) 2019; 25
S Yildiz (4681_CR59) 2016; 25
A Toychiev (4681_CR64) 2018; 117
P Lichtenstein (4681_CR2) 2000; 343
Z He (4681_CR45) 2019; 68
BA Rene (4681_CR10) 2009; 80
LR Krogsgaard (4681_CR12) 2015; 13
CG Buffie (4681_CR49) 2015; 517
GL Hold (4681_CR52) 2014; 20
V Pascal (4681_CR50) 2017; 66
J Wirbel (4681_CR39) 2019; 25
G Zeller (4681_CR3) 2014; 10
CR Stensvold (4681_CR57) 2018; 34
S Chandramathi (4681_CR68) 2010; 106
S Padukone (4681_CR72) 2017; 7
J Yu (4681_CR37) 2017; 66
S Tomkovich (4681_CR43) 2017; 77
S Jahani-Sherafat (4681_CR4) 2018; 11
AD Kostic (4681_CR48) 2014; 146
SH Wong (4681_CR40) 2019; 16
CR Stensvold (4681_CR16) 2007; 23
B Böhm-Gloning (4681_CR33) 1997; 2
S Khademvatan (4681_CR20) 2018; 11
J Sankarasubramanian (4681_CR54) 2020; 7
C Nourrisson (4681_CR61) 2014; 9
S Khademvatan (4681_CR21) 2017; 66
K Machiels (4681_CR51) 2014; 63
TC Tan (4681_CR25) 2008; 104
O Yersal (4681_CR66) 2016; 65
V Kumarasamy (4681_CR67) 2014; 7
S Chandramathi (4681_CR15) 2012; 106
V Kumarasamy (4681_CR69) 2017; 12
DM Parkin (4681_CR1) 2006; 118
P Louis (4681_CR44) 2014; 12
C Noel (4681_CR17) 2005; 43
JD Ramirez (4681_CR9) 2014; 22
S Leelayoova (4681_CR8) 2008; 79
F Dogruman-Al (4681_CR24) 2008; 103
M Ozyurt (4681_CR28) 2008; 57
H Tjalsma (4681_CR47) 2012; 10
AM Mohamed (4681_CR65) 2017; 12
MS Jones (4681_CR29) 2009; 104
H Tilg (4681_CR42) 2018; 33
V Kumarasamy (4681_CR56) 2018; 24
KH Wong (4681_CR26) 2008; 102
AL Engsbro (4681_CR60) 2014; 46
Q Feng (4681_CR36) 2015; 6
M Prosberg (4681_CR53) 2016; 51
O Partida-Rodríguez (4681_CR55) 2017; 48
A Lasry (4681_CR73) 2016; 17
V Kumarasamy (4681_CR71) 2013; 112
CR Stensvold (4681_CR19) 2016; 65
V Iebba (4681_CR62) 2016; 10
M Kök (4681_CR58) 2019; 30
SSR Ajjampur (4681_CR22) 2016; 65
K Tamura (4681_CR34) 2013; 28
F Berrilli (4681_CR63) 2012; 2
KH Chan (4681_CR70) 2012; 110
MA Alfellani (4681_CR5) 2013; 140
M Castellarin (4681_CR35) 2012; 22
OO Coker (4681_CR41) 2019; 68
References_xml – volume: 106
  start-page: 267
  year: 2012
  ident: 4681_CR15
  publication-title: Trans R Soc Trop Med Hyg
  doi: 10.1016/j.trstmh.2011.12.008
– volume: 10
  start-page: 575
  year: 2012
  ident: 4681_CR47
  publication-title: Nat Rev Microbiol
  doi: 10.1038/nrmicro2819
– volume: 16
  start-page: 690
  year: 2019
  ident: 4681_CR40
  publication-title: Nat Rev Gastroenterol Hepatol.
  doi: 10.1038/s41575-019-0209-8
– volume: 77
  start-page: 2620
  year: 2017
  ident: 4681_CR43
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-16-3472
– volume: 2
  start-page: 771
  year: 1997
  ident: 4681_CR33
  publication-title: Trop Med Int Health.
  doi: 10.1046/j.1365-3156.1997.d01-383.x
– volume: 106
  start-page: 941
  year: 2010
  ident: 4681_CR68
  publication-title: Parasitol Res
  doi: 10.1007/s00436-010-1764-7
– volume: 17
  start-page: 230
  year: 2016
  ident: 4681_CR73
  publication-title: Nat Immunol
  doi: 10.1038/ni.3384
– volume: 11
  start-page: 43
  year: 2018
  ident: 4681_CR20
  publication-title: J Infect Public Health.
  doi: 10.1016/j.jiph.2017.03.009
– volume: 80
  start-page: 588
  year: 2009
  ident: 4681_CR10
  publication-title: Am J Trop Med Hyg
  doi: 10.4269/ajtmh.2009.80.588
– volume: 9
  year: 2014
  ident: 4681_CR61
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0111868
– volume: 68
  start-page: 289
  year: 2019
  ident: 4681_CR45
  publication-title: Gut
  doi: 10.1136/gutjnl-2018-317200
– volume: 66
  start-page: 813
  year: 2017
  ident: 4681_CR50
  publication-title: Gut
  doi: 10.1136/gutjnl-2016-313235
– volume: 65
  start-page: 772
  year: 2016
  ident: 4681_CR22
  publication-title: Parasitol Int.
  doi: 10.1016/j.parint.2016.05.007
– volume: 11
  start-page: 2848
  year: 2017
  ident: 4681_CR14
  publication-title: ISME J
  doi: 10.1038/ismej.2017.139
– volume: 7
  year: 2020
  ident: 4681_CR54
  publication-title: Front Med
  doi: 10.3389/fmed.2020.606298
– volume: 65
  start-page: 763
  year: 2016
  ident: 4681_CR19
  publication-title: Parasitol Int
  doi: 10.1016/j.parint.2016.05.015
– volume: 7
  start-page: 162
  year: 2014
  ident: 4681_CR67
  publication-title: Parasit Vectors.
  doi: 10.1186/1756-3305-7-162
– volume: 112
  start-page: 3551
  year: 2013
  ident: 4681_CR71
  publication-title: Parasitol Res.
  doi: 10.1007/s00436-013-3538-5
– volume: 12
  year: 2017
  ident: 4681_CR69
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0183097
– volume: 22
  start-page: 24
  year: 2008
  ident: 4681_CR6
  publication-title: Mol Cell Probes.
  doi: 10.1016/j.mcp.2007.06.007
– volume: 25
  start-page: 679
  year: 2019
  ident: 4681_CR39
  publication-title: Nat Med
  doi: 10.1038/s41591-019-0406-6
– volume: 343
  start-page: 78
  year: 2000
  ident: 4681_CR2
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200007133430201
– volume: 33
  start-page: 954
  year: 2018
  ident: 4681_CR42
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2018.03.004
– volume: 24
  start-page: 3172
  year: 2018
  ident: 4681_CR56
  publication-title: Curr Pharm Des.
  doi: 10.2174/1381612824666180807101536
– volume: 12
  start-page: 21
  year: 2017
  ident: 4681_CR65
  publication-title: Infect Agent Cancer.
  doi: 10.1186/s13027-017-0131-z
– volume: 118
  start-page: 3030
  year: 2006
  ident: 4681_CR1
  publication-title: Int J Cancer
  doi: 10.1002/ijc.21731
– volume: 38
  start-page: 1324
  year: 2000
  ident: 4681_CR32
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.38.4.1324-1330.2000
– volume: 90
  start-page: 326
  year: 2014
  ident: 4681_CR13
  publication-title: FEMS Microbiol Ecol
  doi: 10.1111/1574-6941.12396
– volume: 23
  start-page: 93
  year: 2007
  ident: 4681_CR16
  publication-title: Trends Parasitol.
  doi: 10.1016/j.pt.2007.01.004
– volume: 103
  start-page: 685
  year: 2008
  ident: 4681_CR24
  publication-title: Parasitol Res
  doi: 10.1007/s00436-008-1031-3
– volume: 25
  start-page: 667
  year: 2019
  ident: 4681_CR38
  publication-title: Nat Med
  doi: 10.1038/s41591-019-0405-7
– volume: 34
  start-page: 369
  year: 2018
  ident: 4681_CR57
  publication-title: Trends Parasitol.
  doi: 10.1016/j.pt.2018.02.004
– volume: 117
  start-page: 3715
  year: 2018
  ident: 4681_CR64
  publication-title: Parasitol Res
  doi: 10.1007/s00436-018-6070-9
– volume: 7
  start-page: 122
  year: 2017
  ident: 4681_CR72
  publication-title: Trop Parasitol.
– volume: 30
  start-page: 40
  year: 2019
  ident: 4681_CR58
  publication-title: Turk J Gastroenterol.
– volume: 104
  start-page: 341
  year: 2009
  ident: 4681_CR29
  publication-title: Parasitol Res
  doi: 10.1007/s00436-008-1198-7
– volume: 517
  start-page: 205
  year: 2015
  ident: 4681_CR49
  publication-title: Nature
  doi: 10.1038/nature13828
– volume: 22
  start-page: 299
  year: 2012
  ident: 4681_CR35
  publication-title: Genome Res
  doi: 10.1101/gr.126516.111
– volume: 68
  start-page: 654
  year: 2019
  ident: 4681_CR41
  publication-title: Gut
  doi: 10.1136/gutjnl-2018-317178
– volume: 46
  start-page: 204
  year: 2014
  ident: 4681_CR60
  publication-title: Scand J Infect Dis
  doi: 10.3109/00365548.2013.861609
– volume: 51
  start-page: 1407
  year: 2016
  ident: 4681_CR53
  publication-title: Scand J Gastroenterol
  doi: 10.1080/00365521.2016.1216587
– volume: 104
  start-page: 85
  year: 2008
  ident: 4681_CR25
  publication-title: Parasitol Res
  doi: 10.1007/s00436-008-1163-5
– volume: 65
  start-page: 278
  year: 2016
  ident: 4681_CR46
  publication-title: Gut
  doi: 10.1136/gutjnl-2014-307241
– volume: 3
  start-page: 26
  year: 2013
  ident: 4681_CR18
  publication-title: Trop Parasitol.
  doi: 10.4103/2229-5070.113896
– volume: 22
  start-page: 223
  year: 2014
  ident: 4681_CR9
  publication-title: Infect Genet Evol.
  doi: 10.1016/j.meegid.2013.07.020
– volume: 102
  start-page: 663
  year: 2008
  ident: 4681_CR26
  publication-title: Parasitol Res
  doi: 10.1007/s00436-007-0808-0
– volume: 110
  start-page: 2475
  year: 2012
  ident: 4681_CR70
  publication-title: Parasitol Res
  doi: 10.1007/s00436-011-2788-3
– volume: 126
  start-page: 121
  year: 2004
  ident: 4681_CR7
  publication-title: Vet Parasitol
  doi: 10.1016/j.vetpar.2004.09.017
– volume: 8
  year: 2012
  ident: 4681_CR11
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1002545
– volume: 25
  start-page: 489
  year: 2016
  ident: 4681_CR59
  publication-title: J Gastrointestin Liver Dis.
  doi: 10.15403/jgld.2014.1121.254.yiz
– volume: 63
  start-page: 1275
  year: 2014
  ident: 4681_CR51
  publication-title: Gut
  doi: 10.1136/gutjnl-2013-304833
– volume: 43
  start-page: 348
  year: 2005
  ident: 4681_CR17
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.43.1.348-355.2005
– volume: 11
  start-page: 101
  year: 2018
  ident: 4681_CR4
  publication-title: Gastroenterol Hepatol Bed Bench.
– volume: 57
  start-page: 300
  year: 2008
  ident: 4681_CR28
  publication-title: Parasitol Int
  doi: 10.1016/j.parint.2008.01.004
– volume: 2
  start-page: 141
  year: 2012
  ident: 4681_CR63
  publication-title: Front Cell Infect Microbiol.
  doi: 10.3389/fcimb.2012.00141
– volume: 20
  start-page: 1192
  year: 2014
  ident: 4681_CR52
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v20.i5.1192
– volume: 12
  start-page: 661
  year: 2014
  ident: 4681_CR44
  publication-title: Nat Rev Microbiol
  doi: 10.1038/nrmicro3344
– volume: 48
  start-page: 690
  year: 2017
  ident: 4681_CR55
  publication-title: Arch Med Res
  doi: 10.1016/j.arcmed.2017.11.015
– volume: 140
  start-page: 966
  year: 2013
  ident: 4681_CR5
  publication-title: Parasitology.
  doi: 10.1017/S0031182013000255
– volume: 13
  issue: 507–13
  year: 2015
  ident: 4681_CR12
  publication-title: Clin Gastroenterol Hepatol
– volume: 102
  start-page: 853
  year: 2008
  ident: 4681_CR27
  publication-title: Parasitol Res
  doi: 10.1007/s00436-007-0833-z
– volume: 10
  start-page: 766
  year: 2014
  ident: 4681_CR3
  publication-title: Mol Syst Biol.
  doi: 10.15252/msb.20145645
– volume: 66
  start-page: 70
  year: 2017
  ident: 4681_CR37
  publication-title: Gut
  doi: 10.1136/gutjnl-2015-309800
– volume: 10
  year: 2016
  ident: 4681_CR62
  publication-title: J Infect Dev Ctries.
  doi: 10.3855/jidc.8179
– volume: 16
  start-page: 451
  year: 2016
  ident: 4681_CR31
  publication-title: BMC Infect Dis.
  doi: 10.1186/s12879-016-1776-8
– volume: 79
  start-page: 401
  year: 2008
  ident: 4681_CR8
  publication-title: Am J Trop Med Hyg.
  doi: 10.4269/ajtmh.2008.79.401
– volume: 65
  start-page: 792
  year: 2016
  ident: 4681_CR66
  publication-title: Parasitol Int
  doi: 10.1016/j.parint.2016.02.010
– volume: 54
  start-page: 524
  year: 2016
  ident: 4681_CR23
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.02520-15
– volume: 111
  start-page: 2311
  year: 2012
  ident: 4681_CR30
  publication-title: Parasitol Res.
  doi: 10.1007/s00436-012-3085-5
– volume: 6
  start-page: 6528
  year: 2015
  ident: 4681_CR36
  publication-title: Nat Commun.
  doi: 10.1038/ncomms7528
– volume: 146
  start-page: 1489
  year: 2014
  ident: 4681_CR48
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2014.02.009
– volume: 28
  start-page: 2731
  year: 2013
  ident: 4681_CR34
  publication-title: Mol Biol Evol.
  doi: 10.1093/molbev/msr121
– volume: 66
  start-page: 142
  year: 2017
  ident: 4681_CR21
  publication-title: Parasitol Int
  doi: 10.1016/j.parint.2017.01.005
SSID ssj0060956
Score 2.4049373
Snippet Blastocystis sp. is a common intestinal protozoan found worldwide. Based on gene analysis, 17 subtypes (STs, ST1-ST17) have been identified, 9 of which have...
Background Blastocystis sp. is a common intestinal protozoan found worldwide. Based on gene analysis, 17 subtypes (STs, ST1-ST17) have been identified, 9 of...
Background Blastocystis sp. is a common intestinal protozoan found worldwide. Based on gene analysis, 17 subtypes (STs, ST1–ST17) have been identified, 9 of...
BACKGROUND: Blastocystis sp. is a common intestinal protozoan found worldwide. Based on gene analysis, 17 subtypes (STs, ST1–ST17) have been identified, 9 of...
Abstract Background Blastocystis sp. is a common intestinal protozoan found worldwide. Based on gene analysis, 17 subtypes (STs, ST1–ST17) have been...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 200
SubjectTerms Adult
Age
Age Factors
Aged
Aged, 80 and over
Asymptomatic
Bioethics
Blastocystis
Blastocystis - classification
Blastocystis - genetics
Blastocystis - isolation & purification
Blastocystis Infections - parasitology
Blastocystis Infections - pathology
Blastocystis sp
Cancer
Case-Control Studies
Chemotherapy
Colorectal cancer
Colorectal carcinoma
colorectal neoplasms
Colorectal Neoplasms - parasitology
Colorectal Neoplasms - pathology
Complications and side effects
Deoxyribonucleic acid
Disease control
DNA
DNA, Protozoan - genetics
Europe
Feces - parasitology
Female
genes
Health services
Humans
Infections
Intestine
intestines
Iodine
Irritable bowel syndrome
Light microscopy
Male
Men
Middle Aged
Multivariate analysis
Nucleotide sequence
Optical microscopy
Patients
PCR
Polymerase Chain Reaction
Protozoa
Protozoan diseases
risk
Risk factors
Sex
Sex Factors
ST subtypes
Statistical analysis
Statistics
Surgery
Tumors
Women
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1ba9VAEF6kIPgi3k2tEkXwQdZmr9k8tqWlCvqgFoovy96iQklKcw7Uf-_MJjmcUKgvvh2yk3Dy7c7MN2H2W0LecqG9T1zTVOmGSs8MdSklqlKMzujQRIe7kT9_0adn8tO5Ot866gt7wkZ54BG4faaiC8ALoDSQErXetWoCdy3wdOGbKmL0hZw3F1NjDEYVNT1vkTF6f4BIXUPZzBm2MhpGrxdpKKv134zJW0lp2TC5lYFOHpD7E3UsD8a__JDcSd0jcvdHnz-MPybVEfzA-AU2AefyqnRdLA-BHq_68AdceSiHyw_l3H7VPSFnJ8ffj07pdB4CDVpUK-oMcyZTiMjxUysK32je6OQAXkjbFW_rRnMOxXIIAZiN9iwKr2RrVCOBBzwlO13fpeekbD24XlLB6dhKVysPySw6IWvRYAXDC8JmeGyYxMLxzIoLm4sGo-0IqQVIbYbUXhfk_eaey1Eq41brQ0R9Y4ky1_kCTL6dJt_-a_IL8gbnzKKQRYedMj_dehjsx29f7QFQKzwSSbCCvJuM2h7eIbhp4wEggdpXC8u9hSV4WlgOz0vDTp4-WOCH0gBmoirI680w3onda13q19kGeKuCp9xmg8wWyChg_2xcbRtshABSBa9ekHqxDhfgLUe637-yVrhBPaCG7_4PtF-Qe3x0IcrkHtlZXa3TS6BkK_8qe99fZuAuSw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fi9QwEA56IvhynL_rnVJF8EHitUmapk9yd3icgj6oB4svIU3S8-Bo97a7cP73zqRpvSLs29JMy3aSmfkmnXxDyFvGZV17JqnPZEVFnStqvPe08M4ZJW3lDJ5G_vpNnp2LL4tiETfc-lhWOfrE4KhdZ3GP_BDisFCArnn2cXlNsWsUfl2NLTTukntIXYbJV7mYEi7kUpPjQRklD3vw1yUkzyzHgkaV05tZMAqc_f975luhaV42eSsOne6R3Qgg06Nhxh-SO759RO7_6sL2-GOSncAP9GIgY3FGV6lpXXoMIHnd2T9g0H3aLz-kYxFW-4Scn376eXJGY1cEaiXP1tSo3KgAJBzDDVekv5Gskt6AkiF4Z6wpK8kYpMzWWsA3ss4drwvRqKISgAaekp22a_1zkjY1GKAvrJGuEaYsaghpznBR8grzGJaQfFSPtpEyHDtXXOmQOiipB5VqUKkOKtU3CXk_3bMcCDO2Sh-j1idJJLsOF7rVhY62o_PCGQvQELJDIZDuXxaVZaaBVI3XVeYS8gbnTCOdRYv1Mhdm0_f684_v-ggAFjZG4nlC3kWhpoN3sCYePwBNIAPWTPJgJgn2ZufD49LQ0d57_W91JuT1NIx3Yg1b67tNkAH0WsBTtskgvgVICrp_Nqy2STecA7SCV09IOVuHM-XNR9rL34ExXCErUMVebP_r--QBG4yD5uKA7KxXG_8SINe6fhXs6i9NJycR
  priority: 102
  providerName: ProQuest
Title Colorectal cancer and Blastocystis sp. infection
URI https://www.ncbi.nlm.nih.gov/pubmed/33853659
https://www.proquest.com/docview/2514848730
https://www.proquest.com/docview/2513245553
https://www.proquest.com/docview/2524236232
https://pubmed.ncbi.nlm.nih.gov/PMC8048192
https://doaj.org/article/15dac085282444788659c2af9963b90d
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fa9swED66lkFfytb9qLcueGOwh-HOliXZfhgjKS1doGW0C4S9CFmWu0Gx2ziB9r_fnWyHmpWyp4ToZPAnne47RfoO4COLZZ5bJgMbyizgeZQG2lobCFsUOpUmKzTdRj49kyczPp2L-Qb05Y46AJsHUzuqJzVbXB3c3tx9Q4f_6hw-lV8aXIcTTIpZRAcV0yhATrmFkSmhUg6nfP2vAmmrudtGiZAB5vGiv0Tz4DMGgcrp-f-7at8LW8Mjlfdi1PEz2OnIpT9uZ8Nz2LDVLmwTn2zlmHfh6a_a7aO_gPAQv9Byhx0MDf3C11XhT5BNL2tzh_aN31wf-P1preolzI6Pfh6eBF35hMDIOFwGOo106hhHwWhnlnRyJMuk1TgaGOVDViaZZAxza2MMEiGZR0WcC16mIuNIG17BZlVXdg_8MkdPtcJoWZRcJyLH2FfomCdxRgkP8yDqsVKm0xanEhdXyuUYqVQtvgrxVQ5fdevB53Wf61ZZ41HrCQ3B2pJUsd0P9eJSdU6mIlFogxwS00jOqS6AFJlhusScLs6zsPDgAw2gIt2Lig7WXOpV06jvF-dqjEyMKijFkQefOqOyxncwurungEiQVNbAcn9giY5phs39PFH9vFZIJ3mKmMWhB-_XzdSTDrtVtl45G6S5Ap_ymA0RYeSuiP3rduqtsYlj5GD46h4kg0k5AG_YUv357aTFU5IPytib_wHqLWyz1l-CiO_D5nKxsu-QoS3zETxJ5skItsbj6cUUPydHZz_OR26_Y-Rc8i_j3Tee
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB5VrRBcEG8MBQwCcUCm9u56Yx8QakqrhLYRKq1U9bKsd9cFCdkhTkT7p_iNzPgRaiHl1luUHUf2eB7fbGa_AXjNuMwyx2TgQpkGIouSQDvngthZqxNpUqvpNPLhRI5OxOfT-HQN_nRnYaitsouJdaC2paE98i3MwyJBdM3Dj9NfAU2Non9XuxEajVnsu8vfWLJVH8af8P2-YWxv93hnFLRTBQIjeTgPdBLppE7EltGGJdHHSJZKp_EmMfmFLB-kkjEsOY0xiA9kFlmexSJP4lQwIjrAkL8hOEKFddgY7k6-HHWxn9jbZHc0J5FbFWaIAZbrLKIWyiQKLnrpr54S8H8uuJIM-42aVzLf3h243UJWf7uxsbuw5op7cOOsrDfk70O4gx8obqKMIRua-bqw_hBh-bw0lxhCKr-avve7tq_iAZxci8YewnpRFu4x-HmGLu9io6XNhR7EGSZRq7kY8JQqJ-ZB1KlHmZaknGZl_FR1sZJI1ahUoUpVrVJ14cG75TXThqJjpfSQtL6UJHrt-otydq5ab1VRbLVBMIr1qBA0YEDGqWE6x-KQZ2loPXhF70wRgUZBHTrnelFVavz1SG0jpKNRTDzy4G0rlJf4DEa3Bx5QE8S51ZPc7Emih5v-cmcaqo0wlfrnDx68XC7TldQ1V7hyUcsgXo7xV1bJEKJGEIy6f9RY21I3nCOYw0f3YNCzw57y-ivFj-81R3lCPEQpe7L61l_AzdHx4YE6GE_2n8It1jhKEIlNWJ_PFu4ZAr559rz1Mh--Xbdj_wUF4mOe
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Colorectal+cancer+and+Blastocystis+sp.+infection&rft.jtitle=Parasites+%26+vectors&rft.au=Sul%C3%85%C2%BCyc-Bielicka%2C+Violetta&rft.au=Ko%C3%85odziejczyk%2C+Lidia&rft.au=Adamska%2C+Ma%C3%85gorzata&rft.au=Skotarczak%2C+Bogumi%C3%85a&rft.date=2021-04-14&rft.pub=BioMed+Central+Ltd&rft.issn=1756-3305&rft.eissn=1756-3305&rft.volume=14&rft.issue=1&rft_id=info:doi/10.1186%2Fs13071-021-04681-x&rft.externalDBID=ISR&rft.externalDocID=A658553031
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-3305&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-3305&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-3305&client=summon